Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus

Organ damage is a key determinant of poor long‐term prognosis and early death in patients with systemic lupus erythematosus (SLE). Prevention of damage is a key treatment goal of the 2019 update of the European Alliance of Associations for Rheumatology (EULAR) recommendations for SLE management. Bel...

Descripción completa

Detalles Bibliográficos
Autores principales: Urowitz, Murray B., Aranow, Cynthia, Asukai, Yumi, Bass, Damon L., Bruce, Ian N., Chauhan, Deven, Dall'Era, Maria, Furie, Richard, Fox, Norma Lynn, Gilbride, Jennifer A., Hammer, Anne, Ginzler, Ellen M., Gonzalez‐Rivera, Tania, Levy, Roger A., Merrill, Joan T., Quasny, Holly, Roth, David A., Stohl, William, van Vollenhoven, Ronald, Wallace, Daniel J., Petri, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805003/
https://www.ncbi.nlm.nih.gov/pubmed/35439360
http://dx.doi.org/10.1002/acr.24901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805003/
https://www.ncbi.nlm.nih.gov/pubmed/35439360
http://dx.doi.org/10.1002/acr.24901

Ejemplares similares